New Treatments
Researching Faster Cures
TB Alliance is not just developing new drugs, but changing the way TB drugs are developed.
Learn MoreMore news:
- TB Alliance Statement on New World Health Organization Rapid Communication on Key Changes to the Treatment of Drug-Resistant Tuberculosis
- TB Alliance Welcomes New Data on BPaL-Based Regimens Presented at the 2021 Union Conference
- WHO Global Tuberculosis Report—New Drugs and Regimens Need to be Combined with Equitable and Universal Access
The Latest From TB Alliance
TB by the Numbers
1.5 Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 22 seconds — about 1.5 million people every year.
Get the facts6-30 Months
Today's TB drug regimen takes too long to cure, is too complicated to administer, and can be toxic.
Learn More30+ Projects
Promise in the pipeline means new hope in stopping TB.
Reaching Those In Need
Delivering Treatments
TB Alliance's mission is not complete until new drugs are in the hands of those who need them.
Learn More
Transforming TB Treatment
Charting the Course
We've all come to know the impact of infectious diseases, but we also know the power of science.
Learn MoreMore news:
- Shortfall in TB Research and Development Funding Persists as COVID-19 Erodes Hard-Won Gains
- With tuberculosis resurgent after two years of COVID-19-inspired neglect, TB Alliance is awarded USAID funding to develop new treatments
- Germany’s Federal Ministry of Education and Research (BMBF) Grants Additional Funding to Six PDPs Fighting Poverty-related and Neglected Tropical Diseases
